Betimol



Indications and Reactions:

Role Indications Reactions
Primary
Glaucoma 44.4%
Ocular Hypertension 33.3%
Open Angle Glaucoma 22.2%
Death 50.0%
Cataract Operation 7.1%
Myasthenia Gravis Crisis 7.1%
Pulmonary Embolism 7.1%
Renal Cancer Metastatic 7.1%
Retinal Detachment 7.1%
Urinary Tract Infection 7.1%
Visual Acuity Reduced 7.1%
Secondary
Intraocular Pressure Increased 29.6%
Ill-defined Disorder 14.8%
Glaucoma 11.1%
Chest Pain 4.9%
Musculoskeletal Pain 4.9%
Pain 4.9%
Pain In Extremity 4.9%
Sleep Disorder 4.9%
Blood Cholesterol Increased 3.7%
Discomfort 3.7%
Hypertension 3.7%
Inflammation 3.7%
Abnormal Dreams 1.2%
Blood Cholesterol Abnormal 1.2%
Blood Pressure Abnormal 1.2%
Open Angle Glaucoma 1.2%
Tinnitus 40.0%
Pruritus 13.3%
Discomfort 6.7%
Drug Hypersensitivity 6.7%
Drug Ineffective 6.7%
Headache 6.7%
Pain 6.7%
Urinary Tract Infection 6.7%
Visual Impairment 6.7%
Concomitant
Product Used For Unknown Indication 28.9%
Glaucoma 19.3%
Drug Use For Unknown Indication 10.2%
Hypertension 7.6%
Blood Cholesterol Increased 3.5%
Osteoporosis 3.5%
Gastrooesophageal Reflux Disease 2.9%
Non-small Cell Lung Cancer 2.9%
Diabetes Mellitus 2.3%
Pain 2.3%
Anxiety 2.0%
Chronic Obstructive Pulmonary Disease 2.0%
Intraocular Pressure Increased 2.0%
Bone Disorder 1.8%
Plasma Cell Myeloma 1.8%
Eye Disorder 1.5%
Prostate Cancer 1.5%
Thyroid Disorder 1.5%
Arthralgia 1.2%
Asthma 1.2%
Vomiting 12.5%
Fall 7.1%
Urticaria 7.1%
Weight Decreased 7.1%
Dehydration 5.4%
Intraocular Pressure Increased 5.4%
Myocardial Infarction 5.4%
Rash Pruritic 5.4%
Vision Blurred 5.4%
Death 3.6%
Dizziness 3.6%
Dyspnoea 3.6%
Eye Irritation 3.6%
Fistula 3.6%
Glucose Tolerance Impaired 3.6%
Hepatic Enzyme Increased 3.6%
Insomnia 3.6%
Ischaemic Stroke 3.6%
Metastases To Bone 3.6%
Nausea 3.6%